200+ experts joined online in March 2021, to hear unpublished clinical data and innovative manufacturing processes to accelerate the clinical and commercial development of innate cell therapies.

Download the 2021 full event guide for more information on the discussions around how to target
solid tumor indications with off-the-shelf innate cell therapies!